Ability Biologics
Latest round
- Seed
Last raised
- Jun 2024
Total raised
- $30M
Investors
- 7
About Ability Biologics
, also known as Ability, operates as a premier cell targeting company that offers therapeutic solutions. The company was founded by its CEO, Giles Day. In December 2023, Ability Biologics Inc.vc. Ability Biologics provides AI-based drug discovery and therapeutic solutions. The company also offers the AbiLeap discovery platform, which is a machine learning-based antibody therapeutics discovery platform that discovers and develops human antibodies, mainly IgG-based multispecific antibodies. In addition, the company also develops preclinical antibody candidates and immune modulators for various therapeutic applications, mainly cancer and auto-immune applications.
Who invested in Ability Biologics
7 investors across 2 rounds
See all investors in Ability Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ability Biologics
Who invested in Ability Biologics?
Ability Biologics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ability Biologics raised?
Ability Biologics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ability Biologics last raise money?
Ability Biologics's most recent round on record is a Seed, in Jun 2024.
What does Ability Biologics do?
, also known as Ability, operates as a premier cell targeting company that offers therapeutic solutions.
Where is Ability Biologics headquartered?
Ability Biologics is headquartered in Montreal, Canada.
Which VCs invest in companies like Ability Biologics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ability Biologics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ability Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.